Forcyte Biotechnologies
Forcyte Biotechnologies, based in Los Angeles, develops drugs and offers a platform named FLECS to enhance drug discovery and development, focusing on mechanomics to treat diseases like asthma and hypertension.
Services
Forcyte Biotechnologies offers a specialized platform called FLECS for drug discovery and development. The platform focuses on mechanomics to understand health and disease better. By utilizing patented bioMEMS technology, the company quantifies cell strength and screens hundreds of thousands of drugs against various human cell types. This process aims to map human mechanobiology and create a comprehensive dataset linking genomics, pharmacology, and mechanical cell function.
Industry
Forcyte Biotechnologies operates in the healthcare sector, specifically within the diagnostics sub-industry. The company focuses on understanding cellular mechanisms to develop drugs that control cellular contractility. Their target is mechanically-driven diseases, including asthma, hypertension, and fibrosis. Forcyte Biotechnologies aims to advance medical science by merging genomics, pharmacology, and mechanomics.
Location and Team
Forcyte Biotechnologies is based in Los Angeles, CA, USA. The company has a team size of 5 members. They primarily operate within the United States and the broader Americas and Canada regions. Being a small yet focused team, they leverage their expertise to make significant advancements in the field of healthcare diagnostics and mechanobiology.
Y Combinator W21
Forcyte Biotechnologies was part of the Y Combinator Winter 2021 (W21) batch. Y Combinator is a well-known startup accelerator that supports emerging companies with funding and mentorship. Participation in this program underscores Forcyte Biotechnologies’ potential and innovative approach within the healthcare diagnostics industry.
Mechanomics in Health and Disease
Forcyte Biotechnologies has a strong focus on mechanomics, which examines the mechanical properties of biological systems. The company aims to understand how these properties influence health and disease. By studying cellular contractility and strength, they develop drugs aimed at treating mechanically-driven diseases such as asthma, hypertension, and fibrosis. This focus is highlighted in their blog post titled 'The body is (also) a mechanical system,' published on August 1, 2023.
